CHRONIC INFLAMMATIONS

GeneS S.r.l.

Rome, Italy

GeneS® operates in the biotechnology sector, focusing on applied research in biomolecular technologies. GeneS® aims to bridge market needs and technological innovation in the biotech sector, developing market-fit projects and products. The use of third-generation equipment has allowed us to bring the accuracy and depth of our reports to a clinical level. Our facilities are at the forefront of enhancing tools aimed at preventing disorders and diseases and maximizing the effectiveness of treatments with a view to improving people's quality of life. We use next-generation DNA sequencing (NGS) techniques, which represent the latest frontier in the application of biomolecular technologies to help you improve your health.